CANC Holdings Information

CANC is an equity ETF with a total of 60 individual holdings. The top holdings are Revolution Medicines stock at 5.43%, Merck & Co. at 4.99%, Cogent Biosciences at 4.74%, Eli Lilly and Company at 4.70%, and Novartis AG at 3.78%.

Total Holdings

Top 10 Percentage

40.35%

Asset Class

Equity

ETF Category

Health

Assets

206.87M

PE Ratio

19.80

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	5.43%	55,664
2	MRK	Merck & Co., Inc.	4.99%	69,423
3	COGT	Cogent Biosciences, Inc.	4.74%	307,451
4	LLY	Eli Lilly and Company	4.70%	8,209
5	SWX: NOVN	Novartis AG	3.78%	53,535
6	BMY	Bristol-Myers Squibb Company	3.56%	115,234
7	ABBV	AbbVie Inc.	3.39%	26,349
8	ONC	BeOne Medicines AG	3.38%	19,049
9	GMAB	Genmab A/S	3.20%	187,107
10	HALO	Halozyme Therapeutics, Inc.	3.19%	58,493
11	RHHBY	Roche Holding AG	3.08%	119,440
12	JNJ	Johnson & Johnson	3.08%	23,415
13	EXEL	Exelixis, Inc.	2.92%	103,531
14	IDYA	IDEAYA Biosciences, Inc.	2.68%	145,181
15	CGON	CG Oncology, Inc.	2.66%	79,127
16	IMNM	Immunome, Inc.	2.47%	235,688
17	IOVA	Iovance Biotherapeutics, Inc.	2.38%	448,048
18	BBIO	BridgeBio Pharma, Inc.	2.38%	73,889
19	ELVN	Enliven Therapeutics, Inc.	2.19%	98,433
20	LON: AZN	AstraZeneca PLC	2.12%	26,513
21	ZLAB	Zai Lab Limited	2.04%	164,578
22	RLAY	Relay Therapeutics, Inc.	1.92%	224,406
23	ERAS	Erasca, Inc.	1.84%	269,242
24	LEGN	Legend Biotech Corporation	1.82%	201,984
25	CELC	Celcuity Inc.	1.68%	43,707

Showing 25 of 60 holdings

Subscribe to see the full list

Activate Now

As of Sep 28, 2026